Cargando…
Employing the therapeutic operating characteristic (TOC) graph for individualised dose prescription
BACKGROUND: In current practice, patients scheduled for radiotherapy are treated according to ‘rigid’ protocols with predefined dose prescriptions that do not consider risk-taking preferences of individuals. The therapeutic operating characteristic (TOC) graph is applied as a decision-aid to assess...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606307/ https://www.ncbi.nlm.nih.gov/pubmed/23497640 http://dx.doi.org/10.1186/1748-717X-8-55 |
_version_ | 1782263982398111744 |
---|---|
author | Hoffmann, Aswin L Huizenga, Henk Kaanders, Johannes HAM |
author_facet | Hoffmann, Aswin L Huizenga, Henk Kaanders, Johannes HAM |
author_sort | Hoffmann, Aswin L |
collection | PubMed |
description | BACKGROUND: In current practice, patients scheduled for radiotherapy are treated according to ‘rigid’ protocols with predefined dose prescriptions that do not consider risk-taking preferences of individuals. The therapeutic operating characteristic (TOC) graph is applied as a decision-aid to assess the trade-off between treatment benefit and morbidity to facilitate dose prescription customisation. METHODS: Historical dose-response data from prostate cancer patient cohorts treated with 3D-conformal radiotherapy is used to construct TOC graphs. Next, intensity-modulated (IMRT) plans are generated by optimisation based on dosimetric criteria and dose-response relationships. TOC graphs are constructed for dose-scaling of the optimised IMRT plan and individualised dose prescription. The area under the TOC curve (AUC) is estimated to measure the therapeutic power of these plans. RESULTS: On a continuous scale, the TOC graph directly visualises treatment benefit and morbidity risk of physicians’ or patients’ choices for dose (de-)escalation. The trade-off between these probabilities facilitates the selection of an individualised dose prescription. TOC graphs show broader therapeutic window and higher AUCs with increasing target dose heterogeneity. CONCLUSIONS: The TOC graph gives patients and physicians access to a decision-aid and read-out of the trade-off between treatment benefit and morbidity risks for individualised dose prescription customisation over a continuous range of dose levels. |
format | Online Article Text |
id | pubmed-3606307 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-36063072013-03-27 Employing the therapeutic operating characteristic (TOC) graph for individualised dose prescription Hoffmann, Aswin L Huizenga, Henk Kaanders, Johannes HAM Radiat Oncol Research BACKGROUND: In current practice, patients scheduled for radiotherapy are treated according to ‘rigid’ protocols with predefined dose prescriptions that do not consider risk-taking preferences of individuals. The therapeutic operating characteristic (TOC) graph is applied as a decision-aid to assess the trade-off between treatment benefit and morbidity to facilitate dose prescription customisation. METHODS: Historical dose-response data from prostate cancer patient cohorts treated with 3D-conformal radiotherapy is used to construct TOC graphs. Next, intensity-modulated (IMRT) plans are generated by optimisation based on dosimetric criteria and dose-response relationships. TOC graphs are constructed for dose-scaling of the optimised IMRT plan and individualised dose prescription. The area under the TOC curve (AUC) is estimated to measure the therapeutic power of these plans. RESULTS: On a continuous scale, the TOC graph directly visualises treatment benefit and morbidity risk of physicians’ or patients’ choices for dose (de-)escalation. The trade-off between these probabilities facilitates the selection of an individualised dose prescription. TOC graphs show broader therapeutic window and higher AUCs with increasing target dose heterogeneity. CONCLUSIONS: The TOC graph gives patients and physicians access to a decision-aid and read-out of the trade-off between treatment benefit and morbidity risks for individualised dose prescription customisation over a continuous range of dose levels. BioMed Central 2013-03-07 /pmc/articles/PMC3606307/ /pubmed/23497640 http://dx.doi.org/10.1186/1748-717X-8-55 Text en Copyright ©2013 Hoffmann et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Hoffmann, Aswin L Huizenga, Henk Kaanders, Johannes HAM Employing the therapeutic operating characteristic (TOC) graph for individualised dose prescription |
title | Employing the therapeutic operating characteristic (TOC) graph for individualised dose prescription |
title_full | Employing the therapeutic operating characteristic (TOC) graph for individualised dose prescription |
title_fullStr | Employing the therapeutic operating characteristic (TOC) graph for individualised dose prescription |
title_full_unstemmed | Employing the therapeutic operating characteristic (TOC) graph for individualised dose prescription |
title_short | Employing the therapeutic operating characteristic (TOC) graph for individualised dose prescription |
title_sort | employing the therapeutic operating characteristic (toc) graph for individualised dose prescription |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606307/ https://www.ncbi.nlm.nih.gov/pubmed/23497640 http://dx.doi.org/10.1186/1748-717X-8-55 |
work_keys_str_mv | AT hoffmannaswinl employingthetherapeuticoperatingcharacteristictocgraphforindividualiseddoseprescription AT huizengahenk employingthetherapeuticoperatingcharacteristictocgraphforindividualiseddoseprescription AT kaandersjohannesham employingthetherapeuticoperatingcharacteristictocgraphforindividualiseddoseprescription |